Goldman Sachs’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-39,872
Closed -$482K – 6664
2021
Q1
$482K Buy
+39,872
New +$791K ﹤0.01% 5153

Other funds holding LHDX

Goldman Sachs's LHDX Position: Q2 2021 in Review

Goldman Sachs sold out of Lucira Health, Inc. Common Stock (LHDX) in Q2 2021, closing a stake of 39,872 shares — an estimated $482K sold.

Goldman Sachs first reported a position in LHDX in Q1 2021 and held it in 1 quarter. The position peaked at $482K in Q1 2021. 44 funds tracked by Wall St. Rank hold LHDX as of Q2 2021.

  • Goldman Sachs reported no remaining Lucira Health, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Goldman Sachs sold 39,872 Lucira Health, Inc. Common Stock shares in Q2 2021, an estimated $482K.
  • Goldman Sachs first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Goldman Sachs's Lucira Health, Inc. Common Stock position peaked at $482K in Q1 2021.
  • 44 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q2 2021.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.